In a welcome move, HealthEquity saw its Relative Strength Rating improve from 70 to 74 on Tuesday.
How To Invest In Stocks In Both Bull And Bear Markets
This unique rating measures technical performance by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
History shows that the market's biggest winners typically have an RS Rating north of 80 as they begin their biggest climbs. See if HealthEquity can continue to rebound and clear that threshold.
While it's not currently an ideal time to jump in, see if the stock goes on to offer and clear a proper buy point.
The company posted 10% earnings growth in the latest quarterly report. Sales gains came in at 19%.
HealthEquity holds the No. 4 rank among its peers in the Commercial Services-Outsourcing industry group. ExlService Holdings is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Technical Action?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
